MarginsXMarginsX
Home › Markets › YBGJ

Yubo International Biotech Ltd (YBGJ)

YBGJ is quoted over the counter, not listed on an exchange. Yubo International Biotech Ltd files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Close · November 13, 2026
$0.0055
-32.1% on the day
1-year return
-62.3%
Market cap
$937K
Nano cap. From the Nov 13, 2026 close × 170.4M shares (10-Q cover page, Nov 10, 2026)
P/E and P/S
Net loss over the period · 75.9×
On trailing twelve months to September 30, 2026 (10-Q)

Closes: Yahoo Finance daily closes, last bar 2026-11-13.

Profile

FieldValue
TickerYBGJ, quoted over the counter
SEC CIK0000895464
OTC Markets tierOTCID (price source, 2026-11-13)
SEC industry codeElectromedical & Electrotherapeutic Apparatus
Business addressBeijing, China
Incorporated inNY

Warning signs

Cash runway
0.3 months
$9K cash at September 30, 2026
Share count, 1 year
No year-earlier count
Going-concern doubt
Yes
10-Q filed November 10, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern for a reasonable period of time."
10-Q 2026-11-10
Cash and burn$9K cash; operating cash flow -$105K a quarter.Report 2026-09-30
Shares outstanding170,420,790 (2026-11-10).Cover page 2026-11-10
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorHCL,PLLC, Chicago, Illinois, United States; changed auditors 3 times in 24 months8-K 4.01 2026-01-16
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2027
2026-09-30
$0-$188K-$157$9KNo debt tags$12K10-Q 2026-11-10
Q1 2027
2026-06-30
$0-$248K-$84K$12KNo debt tags$12K10-Q 2026-08-14
Q1 2027
2026-03-31
$0-$273K-$207K$10KNo debt tags$12K10-Q 2026-05-15
Q3 2026
2025-12-31
$12K-$261K-$129K$8KNo debt tags$12K10-K 2026-03-31
Q2 2026
2025-09-30
$0-$277K-$308K$11KNo debt tags-$1810-Q 2026-11-10
Q1 2026
2025-06-30
$0-$230K-$14K$10KNo debt tags-$1810-Q 2026-08-14
Q1 2026
2025-03-31
$0-$436K-$392K$10KNo debt tags-$1810-Q 2026-05-15
Q3 2025
2024-12-31
-$18-$147K-$933K$7KNo debt tags$3K10-K 2026-03-31

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32022-11-16
Latest annual report10-K2026-03-31
Latest quarterly / interim10-Q2026-11-10
Latest current report8-K2026-01-16
Latest proxyDEF 14A2001-08-08

Source: SEC EDGAR submissions feed, 285 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier